Compounds for treatment of alzheimer’s disease

The invention relates to certain chromanol, quinone or hydroquinone compounds and ‘ derivatives thereof for treatment of Alzheimer’s disease and/or for improving memory , function. Specifically, the present invention relates to chromanol compounds chosen from (6— \ 5 hydroxy-2,5,7,8—tetramethylchroman—Zyl)(piperazin-l -yl)methanone, ((S)-6-hydroxy-2,5,7,8~ tetramethyl—N—((R)-piperidin—3—yl)chroman—2—carboxamide hydrochloride and S-(6—hydroxy— 2,5 ,7, 8~tetramethylchroman—2-yl)(4-(2—hydroxyethyl)piperazin- 1 -y1)methanone, and pharmaceutically acceptable salts thereof

Compounds for treatment of alzheimer’s disease

The invention relates to certain chromanol, quinone or hydroquinone compounds and ‘ derivatives thereof for treatment of Alzheimer’s disease and/or for improving memory , function. Specifically, the present invention relates to chromanol compounds chosen from (6— \ 5 hydroxy-2,5,7,8—tetramethylchroman—Zyl)(piperazin-l -yl)methanone, ((S)-6-hydroxy-2,5,7,8~ tetramethyl—N—((R)-piperidin—3—yl)chroman—2—carboxamide hydrochloride and S-(6—hydroxy— 2,5 ,7, 8~tetramethylchroman—2-yl)(4-(2—hydroxyethyl)piperazin- 1 -y1)methanone, and pharmaceutically acceptable salts thereof